Germany Becomes First European Country to Approve Compassionate Use of Psilocybin

Germany has become the first EU country to approve compassionate-use access for psilocybin therapy to treat treatment resistant depression at two specialized clinics. Filament Health’s botanical psilocybin candidate, PEX010, is the drug product authorized for this program, marking a milestone in psychedelic medicine access in Europe.